Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• Traditionally, many significant investment opportunities in the space industry were only accessible to venture capital and institutional investors, leaving retail investors unable to participate.
• However, Planet Ventures Inc. is changing this, as the company provides shareholders with indirect exposure to private space and aerospace companies through a publicly traded investment vehicle.
• A variety of companies stretch under Planet Ventures’ belt, including areas like software, energy, robotics, emerging applications, and infrastructure.

The commercial space economy is entering a new phase of growth. What was once dominated by government agencies is rapidly evolving into a global industry encompassing satellite communications, orbital infrastructure, artificial intelligence, robotics, energy systems, and even lunar development. With industry forecasts projecting the space economy is projected to surpass $1 trillion in value over the coming decades, investors are increasingly looking for ways to participate in this transformation.

Yet many of the most promising opportunities remain inaccessible to everyday investors. Historically, exposure to emerging space companies has largely been reserved for venture capital firms, institutional investors, and private funding networks, leaving retail investors with limited options to gain meaningful participation in the sector’s growth.

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) is helping bridge that gap. As a publicly traded investment issuer focused on the space and aerospace industries, the company provides investors with indirect exposure to a portfolio of private and early-stage businesses developing technologies that could help shape the future of the next frontier.

Planet Ventures’ strategy centers on identifying innovative companies operating across key segments of the emerging space economy and allocating capital to businesses positioned to benefit from long-term industry expansion. Through this approach, shareholders gain access to opportunities spanning orbital infrastructure, energy systems, artificial intelligence, robotics, and lunar development through a single public-market vehicle.

The company’s portfolio reflects several of the most important themes driving the next generation of space commercialization. Planet Ventures has invested in Relativity Space, a launch infrastructure company led by former Google CEO Eric Schmidt; Mantis Space, which is developing what it describes as the world’s first orbital power grid; and Antaris Inc., whose AI-powered software platform is designed to simplify satellite constellation design, simulation, and operations.

The company has also  made an investment into Galactic Resource Utilization Space Inc., which is pursuing lunar infrastructure and space tourism initiatives, including plans for a lunar hotel; General Astronautics, a developer of autonomous robotics systems for microgravity research and development; and Lux Aeterna, which is building a fully reusable satellite platform designed to support future space operations.

Collectively, these investments provide exposure to several of the technologies expected to underpin the expanding commercial space ecosystem. From orbital energy generation and AI-driven mission management to robotics and lunar infrastructure, Planet Ventures is building a portfolio aligned with the industry’s long-term evolution.

Leading the effort is CEO Etienne Moshevich alongside Executive Director Desmond Balakrishnan and a team of experienced professionals spanning capital markets, finance, technology, and business development. The company recently strengthened its space-focused investment expertise with the appointment of Dr. Bora Uygun as Head of Space Investments. A recognized entrepreneur and active angel investor, Uygun brings extensive experience across aerospace, artificial intelligence, telecommunications, and fintech.

As commercial activity in orbit continues to expand and private capital increasingly drives innovation beyond Earth, Planet Ventures offers retail investors a rare opportunity to gain exposure to private companies operating at the forefront of the space economy through a publicly traded investment platform.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. 

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities

• Forward Industries, a Solana (SOL) treasury company that buys, holds, and strategically deploys SOL, has announced that it will soon join the Russell 2000(R) and 3000(R) indexes.
• Forward will join the indexes as a part of Russell indexes semi-annual reconstitution in June, which captures the 3,000 largest US stocks as of April 30, 2026, and ranks them by market capitalization.
• The move is an important milestone for Forward and reinforces the growing institutional recognition of Forward’s Solana treasury strategy.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced that it is set to join both the broad-market Russell 3000(R) Index and the small-cap Russell 2000(R) Index (https://ibn.fm/KcXh1). 

The move is a part of Russell indexes’ semi-annual reconstitution, which is effective once the US market opens on June 29, 2026. This semi-annual reconstitution of the Russell US indexes captures the 3,000 largest US stocks as of April 30, 2026, and ranks them by market capitalization.

Companies that gain membership in the Russell 3000(R) Index also gets them automatic membership in the large-cap Russell 1000(R) Index or small-cap Russell 2000(R) Index, and the appropriate value and growth style indexes. FTSE Russell determines membership for its indexes by objective, style attributes, and market capitalization rankings.

Speaking about Forward’s inclusion in the indexes, Ryan Navi, the Chief Investment Officer at Forward Industries said that “Inclusion in the Russell 2000(R) and Russell 3000(R) marks an important milestone for Forward and reinforces the growing institutional recognition of our strategy, scale, and execution. We believe index inclusion will expand our shareholder base, improve trading liquidity, and increase visibility among long-term institutional investors. As we continue executing our disciplined Solana treasury strategy and compounding SOL-per-share, we believe Forward is well-positioned to establish itself as a leading institutional platform for digital asset exposure.”

The SOL treasury strategy that Navi refers to involves Forward accumulating Solana (SOL) and deploying it through on-chain opportunities, such as staking. Currently, it has liquid SOL holdings of over 7 million SOL and Forward’s validator infrastructure has generated between 6.5% and 7.2% gross annual percentage yield (“APY”) before fees since inception, which outperforms other top peer validators.

Also, around 25% of Forward’s SOL holdings are fwdSOL, which is Forward’s proprietary liquid staking token that lets it maintain liquidity, while earning native staking yield.

About Forward Industries Inc. (NASDAQ: FWDI)

Forward Industries is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital space. It looks to generate long-term shareholder value through actively participating in the Solana ecosystem. Specifically, it aims to accumulate SOL and strategically deploy assets through various on-chain opportunities like participating in decentralized finance (“DeFi”), staking, and lending.

For more information, visit the Forward Industries website at www.ForwardIndustries.com.

NOTE TO INVESTORS: The latest news and updates relating to FWDI are available in the company’s newsroom at https://ibn.fm/FWDI

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd.
• Ocean Partners will purchase 100% of ESGold’s dore production, in exchange for a non-dilutive working capital facility of up to C$9 million
• Delivery of the dore will be made EXW at the Montauban Project Mine site, with Ocean Partners responsible for collection and related logistics
• The agreement was based on prevailing LBMA or COMEX market prices

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd. With the agreement, Ocean Partners is set to purchase 100% of dore production from ESGold’s flagship Montauban Project. In return, ESGold will gain access to a non-dilutive working capital facility of up to C$9 million (https://ibn.fm/deTSj).

While making the announcement, ESGold’s CEO, Gordon Robb noted just how big of a milestone this is for the company, noting how it marks an evolution from a development company to a near-term producer. “Ocean Partners is an internationally respected organization with extensive experience across metals trading, mine finance, and global mining operations,”  he noted. “Securing a definitive agreement with a group of this caliber significantly strengthens our production strategy and validates the progress our team has made behind the scenes,” he added (https://ibn.fm/deTSj).

The C$9 million in working capital will be available to ESGold in two tranches. The first tranche will come in at C$3 million, with the second at $6 million, subject to satisfaction of applicable conditions precedent. ESGold will retain strategic flexibility regarding timing and use of the facility, however, the agreement outlines a minimum delivery commitment totaling 50,000 ounces of gold and 1,000,000 ounces of silver over the term of the said agreement, as based on projected production scenarios and development plans (https://ibn.fm/deTSj). 

Delivery will be made EXW at the Montauban Project Mine site, with Ocean Partners responsible for collection and related logistics. For ESGold, the arrangement supports operational flexibility, particularly now as the company advances mill construction, commissioning, and production ramp-up activities. 

“What is particularly exciting is the stage we are now entering as a company. While we continue advancing mill construction and infrastructure toward production, we are simultaneously conducting modern exploration and geological investigation at Montauban,” Robb noted. “We are systematically and methodically advancing both sides of the production and exploration story of ESGold at the same time. With the expanded ANT survey underway, drilling preparations advancing, production equipment continuing to arrive on site, and a comprehensive district-scale geological model continuing to evolve,” he added (https://ibn.fm/deTSj). 

This pricing agreement is based on prevailing LBMA or COMEX market prices. Ocean Partners will be paying for 99.8% of contained gold and 99% of contained silver, subject to standard refining charges of US$0.80 per payable ounce of gold and US$0.50 per payable ounce of silver.

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Humanitas collaboration supports Regentis’ physician adoption strategy and broader commercial infrastructure across the European market.
• GelrinC targets a large orthopedic market that currently lacks an approved off-the-shelf regenerative cartilage repair solution.
• Pivotal FDA enrollment, manufacturing scale-up, physician engagement initiatives and CE Mark status position the company toward multiple potential value-inflection milestones.

Regenerative medicine has long promised to transform patient care, but investors often become most interested when innovative science begins transitioning toward commercial adoption. Regentis Biomaterials (NYSE American: RGNT) is approaching that transition with GelrinC(R), its cartilage regeneration platform targeting a large orthopedic market where treatment alternatives continue to involve meaningful trade-offs. The opportunity is significant. Approximately 470,000 cases of focal knee cartilage damage are treated annually in the United States, yet physicians still lack a broadly available FDA-approved off-the-shelf regenerative cartilage repair solution.  For investors, the central question may be straightforward: what happens if a company successfully introduces a simple regenerative solution into a market where no directly comparable option currently exists?

Beyond the clinical need, GelrinC’s simplicity may prove important from a commercialization standpoint. Unlike more complex cell-based therapies that require tissue harvesting, laboratory processing and multiple procedures, GelrinC is designed for straightforward integration into existing surgical workflows. For investors, that combination of procedural simplicity and regenerative potential could support future physician adoption if clinical and regulatory milestones continue to be achieved 

Clinical results published to date have demonstrated sustained pain relief and functional improvement for more than five years, while imaging assessments suggesting near-complete structural cartilage repair. For investors, these findings are important because they indicate both improved patient outcomes and structural tissue restoration GelrinC has already received CE Mark approval in Europe and is currently being evaluated in a pivotal FDA study that has surpassed 50% enrollment.

Regentis is also taking visible steps toward commercialization. In April 2026, the company announced a collaboration with Humanitas Research Hospital in Milan and cartilage regeneration expert Prof. Elizaveta Kon to support its European Centers of Excellence strategy. Beyond scientific collaboration, these initiatives may help build physician familiarity, surgeon engagement and future adoption pathways ahead of broader commercialization efforts. Operational preparation is advancing as well. Earlier this year, Regentis announced a solvent-free manufacturing process that more than quadrupled GelrinC production yield per batch while improving efficiency and scalability. Although manufacturing developments often receive less attention than clinical milestones, experienced healthcare investors frequently view manufacturing readiness as an important indicator of commercial preparedness Looking ahead, investors may be focused on several potential value inflection events, including completion of pivotal study enrollment, additional clinical follow-up data, regulatory progress, potential PMA submission and continued commercialization initiatives in Europe. Each milestone has the potential to reduce uncertainty and increase investor attention as the company advances toward possible commercialization. Beyond GelrinC itself, the company’s proprietary Gelrin hydrogel platform may also provide future opportunities through additional indications, partnerships or licensing activities.

With regulatory progress, manufacturing scale-up and physician engagement initiatives advancing simultaneously, Regentis appears to be entering a period where execution may become increasingly important to the investment story. As the company moves closer to potential commercialization, investor attention may increasingly focus not simply on whether cartilage regeneration is possible but whether Regentis can successfully convert its clinical foundation into physician adoption, commercial traction and long-term value creation.

For more information, visit the company’s website at www.Regentis.co.il.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at ibn.fm/RGNT

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

• The importance of rare earth elements has grown significantly alongside the global energy transition.
• Canamera Energy Metals is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. 
• The company also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil.

Rare earth elements are becoming increasingly essential to the modern global economy, powering technologies that range from electric vehicles and renewable energy systems to advanced defense applications and consumer electronics. As governments and industries push to secure stable supplies of these critical materials outside of dominant supply regions, companies advancing new rare earth projects are drawing heightened attention. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is positioning itself within that growing strategic landscape through continued progress at its Brazilian rare earth projects, highlighted by recent announcements involving accelerated exploration activities and the filing of an independent technical report.

The importance of rare earth elements has grown significantly alongside the global energy transition. According to the International Energy Agency, critical minerals such as rare earths are essential for technologies tied to electrification, clean energy and advanced manufacturing, with demand expected to rise substantially over the coming decades. Rare earth magnets are used extensively in electric motors, wind turbines and precision electronic systems because of their strength and efficiency.

At the same time, supply-chain concentration remains a major concern. China continues to dominate global rare earth mining and processing capacity, leading western governments and industries to prioritize the development of alternative supply sources. Analysis from the Center for Strategic and International Studies notes that China controls roughly 70% of rare earth mining and approximately 90% of processing capacity, underscoring the strategic importance of projects located in other jurisdictions. This backdrop has increased interest in countries such as Brazil, which hosts significant rare earth potential but remains comparatively underexplored.

Canamera’s recent announcements indicate the company is continuing to move aggressively to expand and define its rare earth assets in Brazil and strengthen its position in the REE space. The company is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. The company stated that the expanded program is designed to further evaluate ionic clay-hosted rare earth mineralization across the property.

Ionic clay deposits are especially significant within the rare earth industry because they can often be processed using relatively simpler and lower-cost extraction methods compared with hard rock rare earth deposits. Brazil has increasingly attracted attention for this type of mineralization because some of its geological formations resemble the ionic clay systems historically developed in southern China.

Canamera’s announcement noted that the accelerated exploration program follows encouraging early drilling and sampling results at Turvolândia. The company stated that it plans to increase auger drilling density, expand target areas and continue metallurgical and geological evaluation work. This type of systematic exploration approach is important because it allows the company to better define the scale, continuity and characteristics of the mineralized zones.

Canamera also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil. Technical reports prepared under NI 43-101 standards are significant milestones for mineral exploration companies because they provide independently reviewed geological and technical information intended to meet regulatory disclosure standards.

According to the company, the report supports the geological prospectivity of the Jaguaribe property and provides additional technical context regarding the project’s rare earth mineralization potential. Independent reports can help strengthen the credibility of exploration programs by providing outside verification and analysis of project data.

Together, these two developments suggest Canamera is advancing along multiple fronts simultaneously. The company is not only continuing active field exploration at Turvolândia but also formalizing technical documentation and disclosure around Jaguaribe. This combination of ongoing exploration and technical advancement reflects a broader effort to build a diversified rare earth portfolio in Brazil.

The company’s strategy appears aligned with growing geopolitical and industrial trends favoring diversified rare earth supply chains. As demand for magnet rare earth elements increases, governments and manufacturers are seeking supply relationships that reduce dependence on highly concentrated processing regions. Projects located in jurisdictions with supportive geology and mining potential may therefore become increasingly important to global supply diversification efforts.

Canamera’s focus on ionic clay-hosted rare earth mineralization may also prove strategically important. Ionic clay systems are viewed favorably because of their potential for simpler extraction processes and lower-cost development compared with more complex hard rock projects. Successful development of these types of deposits outside China could help broaden global rare earth supply options.

The company’s recent announcements also indicate that management is working to advance projects through multiple stages of evaluation and development rather than relying solely on conceptual exploration. Accelerating field programs, increasing drilling activity and filing independent technical reports are all steps commonly associated with building project credibility and preparing for longer-term advancement.

As the rare earth sector continues evolving, companies capable of demonstrating both geological potential and systematic project advancement are likely to attract increasing attention from investors and industry participants. Canamera Energy Metals’ recent progress in Brazil reflects this broader trend, positioning the company within a rapidly growing segment of the critical minerals industry.

With rare earth demand continuing to expand alongside electrification, renewable energy deployment and advanced technology manufacturing, the strategic value of new rare earth projects may continue rising. Through its exploration efforts at Turvolândia and its advancing technical work at Jaguaribe, Canamera Energy Metals is working to establish itself as part of the next generation of non-Chinese rare earth development companies.

For more information, visit the company’s website at CanameraMetals.com. 

NOTE TO INVESTORS: The latest news and updates relating to EMETF are available in the company’s newsroom at ibn.fm/EMETF

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This document contains “forward-looking information” within the meaning of applicable securities legislation, including statements regarding: the Company’s planned exploration activities on its projects; the anticipated timing and completion of the earn-in milestones under the Option Agreement; the Company’s ability to make required cash and share payments and incur required exploration expenditures; the geological prospectivity of its projects; and the Company’s exploration strategy.

Forward-looking information is based on assumptions, estimates, and opinions of management at the date the statements are made and is subject to a variety of risks and uncertainties that could cause actual results to differ materially from those anticipated or projected. These assumptions include, without limitation: the Company’s ability to raise sufficient capital to fund its exploration programs and option payments; favourable regulatory conditions; continued access to its projects; and general economic conditions.

Important risk factors that could cause actual results to differ materially include, but are not limited to: uncertainties related to raising sufficient financing; the inherently speculative nature of mineral exploration; title risks; environmental and permitting risks; and fluctuations in uranium prices. Additional risk factors affecting the Company can be found in the Company’s continuous disclosure documents available at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking information.

• Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment.
• In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records.
• Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000.
• Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth.
• The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June.

For many investors evaluating companies on the OTC market, share structure often receives as much attention as revenue growth or acquisition activity. Earth Science Tech (OTC: ETST), a strategic holding company spanning telemedicine, pharmacies, clinical support services, and healthcare fulfillment, has increasingly distinguished itself in share structure and financial stability through a sustained program of share repurchases, which has reduced outstanding shares while the company simultaneously expands its healthcare-focused operating platform.

The company’s most recent Form 10-Q, covering the quarter ended December 31, 2025, provides a detailed look at the pace of those repurchases (https://ibn.fm/Gm12j). According to the filing, Earth Science Tech repurchased 1,143,000 common shares during the quarter for approximately $177,659 through private transactions with shareholders. The purchases included 380,000 shares acquired on October 28, 2025, at $0.08 per share and an additional 763,000 shares purchased on December 10, 2025, at $0.193 per share.

The buyback activity extends well beyond a single quarter. For the nine months ended December 31, 2025, the company reported repurchasing 3,703,296 shares for a total cost of approximately $647,087. Those transactions included purchases of 1,050,296 shares in April 2025, 1,510,000 shares in September 2025, 380,000 shares in October 2025 and 763,000 shares in December 2025.

The significance of those repurchases becomes more apparent when compared with the company’s current share structure. Earth Science Tech reported 290.6 million shares outstanding as of June 1, 2026. The same data shows a reduction of approximately 715,000 shares during the most recent three-month period, a decline of 1.8 million shares over six months and a decrease of approximately 3.69 million shares over the last twelve months. Those figures closely mirror the repurchase activity disclosed in SEC filings (https://ibn.fm/cxJkG). 

The historical share structure data also provides a timeline of share reductions. Outstanding shares declined from more than 294.3 million in September 2025 to approximately 290.6 million by June 2026, reflecting a series of cancellations and repurchases over that period.

For investors accustomed to seeing microcap companies expand share counts through repeated equity issuance, Earth Science Tech’s approach stands out. The company maintains 300 million authorized shares, leaving relatively limited separation between authorized and outstanding stock. As of June 2026, approximately 215.1 million shares were classified as restricted, while the public float stood at roughly 40.8 million shares.

While share repurchases alone do not determine investment performance, they can provide insight into management’s capital allocation priorities. In ETST’s case, the reduction in outstanding shares suggests an emphasis on preserving shareholder ownership percentages while executing a broader corporate growth strategy.

The company’s growth strategy has successfully evolved over the past several years, transitioning away from its legacy wellness operations and repositioning itself as a diversified holding company focused primarily on healthcare-related businesses. The company now operates through subsidiaries involved in pharmaceutical compounding, telemedicine, clinical support services, healthcare fulfillment, real estate investments and cash management activities.

The central theme behind the model is vertical integration. Management has assembled businesses that participate in multiple stages of the patient-care process, from initial consultation and telehealth interactions to prescription fulfillment and ongoing support services. Telemedicine platforms serve as a front-end entry point for patients seeking medical consultations and treatment options. Compounding pharmacies then provide customized prescription fulfillment, creating recurring interactions that can extend over long periods.

By integrating these functions internally, the company seeks to capture value across multiple stages of the healthcare continuum rather than relying on a single revenue stream. The structure offers exposure to sectors that continue to benefit from long-term healthcare demand trends, including personalized medicine, telehealth adoption and outpatient care delivery.

At the same time, management has continued emphasizing financial discipline. The share repurchase program demonstrates a willingness to deploy capital toward reducing share count while pursuing operating expansion. That balance between acquisition-driven growth and shareholder-focused capital management has become a recurring theme in company communications.

Regarding investor visibility, the company announced that Chairman and Chief Executive Officer Giorgio R. Saumat will present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17 at the Bellagio Resort & Hotel. The event, organized in conjunction with MicroCapClub, brings together microcap companies and investors for presentations and one-on-one meetings. The conference appearance offers management an opportunity to discuss the company’s operating strategy, healthcare platform and capital allocation priorities directly with investors.

For shareholders, however, one of the clearest signals may already be visible in the numbers. While many small-cap and OTC companies face scrutiny over expanding share counts, Earth Science Tech’s recent filings and share structure records show a different pattern. More than 3.7 million shares were repurchased during the nine months ended December 2025, and the company’s outstanding share count has continued trending lower into 2026.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST 

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

• The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level.
• Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for an unmet need in multiple sclerosis.
• The company has also expanded its presence in a consumer ready product in the field of alcohol health and sobriety through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster.

Neurological disorders are increasingly recognized as one of the world’s most significant healthcare challenges as aging populations and rising disease prevalence place growing pressure on healthcare systems globally. According to the World Health Organization, neurological conditions are now the leading cause of illness and disability worldwide, affecting more than one-third of the global population. Despite advances in treatment, many currently approved therapies for neurodegenerative diseases primarily focus on symptom management rather than directly addressing underlying neurodegeneration, leaving substantial unmet medical needs across the sector.  Current drugs for multiple sclerosis do not address loss of mobility and function which remains an unmet patient need today.

Against this backdrop, Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), is advancing a novel, new chemical entity patented approach to multiple sclerosis.. 

The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level. Research that neurological disorders represent the leading cause of disability-adjusted life years globally, underscoring the expanding societal and economic impact of diseases such as Multiple Sclerosis, Alzheimer’s disease and Parkinson’s disease. In the United States alone, neurological disorders generate billions of dollars annually in healthcare costs, lost productivity and long-term care expenses. Researchers and biotechnology companies are increasingly pursuing therapies designed not only to treat symptoms but also to target the mechanisms responsible for neuronal injury and degeneration.

Quantum BioPharma operates as a biopharmaceutical company focused on developing treatments and biotech solutions targeting neurodegenerative, metabolic and alcohol misuse disorders. The company’s business strategy combines clinical-stage therapeutic development with additional biotech and strategic investment initiatives designed to diversify potential value creation opportunities. The company’s lead focus is neurological disease and the advancement of therapies that could potentially address major unmet needs worldwide.

Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for multiple sclerosis. Unlike many currently approved MS therapies that primarily target immune system modulation, Lucid-MS is designed as a neuroprotective therapy focused on preventing myelin degradation, a key driver of neurological damage in multiple sclerosis. 

Quantum BioPharma has reported that preclinical animal model studies demonstrated the compound’s ability to prevent and reverse myelin degradation in disease models. One company-produced video reports on a mouse regaining its ability to walk after treatment witih LUCID-MS.  

While Lucid-MS represents the company’s lead pharmaceutical program, Quantum BioPharma has also expanded its presence into metabolic and alcohol misuse-related wellness technologies through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster. The company developed the original unbuzzd intellectual property and later spun out the over-the-counter version to Unbuzzd Wellness Inc., while retaining a significant ownership position and royalty rights tied to future sales. 

According to Quantum BioPharma, unbuzzd was developed by a research and development team specializing in pharmacology and medicine and is intended to help accelerate alcohol metabolism, restore mental alertness and reduce symptoms associated with alcohol consumption. The product contains a proprietary blend of vitamins, minerals and supplements designed to support liver and brain function after drinking. The company positions the product not simply as a hangover remedy but as part of a broader effort to address societal burdens associated with alcohol misuse and intoxication. 

The company has highlighted growing scientific validation surrounding unbuzzd in a first of its kind clinical study. In March 2026, Quantum BioPharma announced the publication of a peer-reviewed, double-blind, randomized, placebo-controlled crossover clinical study evaluating unbuzzd. According to the published findings, participants receiving unbuzzd experienced reductions in blood alcohol concentration more than 40% faster within the first 30 minutes compared with placebo. The study also reported improvements in alertness, reduced mental fatigue and reductions in hangover symptoms without reported adverse side effects. 

Quantum BioPharma maintains financial participation in the commercialization of unbuzzd through both equity ownership and royalty agreements. The company disclosed that it retains approximately 20% ownership in Unbuzzd Wellness Inc., along with royalty rights equal to 7% of product sales until cumulative royalty payments reach $250 million, after which the royalty rate falls to 3% in perpetuity. The structure provides Quantum BioPharma with potential long-term exposure to the commercialization success of the product while maintaining rights related to pharmaceutical and medical-use formulations. 

The company has also emphasized the commercial leadership supporting the unbuzzd platform. Quantum BioPharma notes that the initiative involves executives and advisors with backgrounds at major consumer beverage companies, including Co-Chair Gerry David, previously the CEO of Celsius Holdings, and John Duffy, previously with The Coca-Cola Company. Another advisor connected to the product is Kevin Harrington, one of the original investors featured on “Shark Tank.”

As neurological disease prevalence continues rising worldwide, biotechnology companies pursuing differentiated therapeutic approaches and adjacent wellness technologies may attract increasing industry attention. Quantum BioPharma’s strategy combines clinical-stage neurodegenerative drug development targeting helping patients get back the mobility and control of their bodies they have lost due to MS with broader commercial initiatives targeting alcohol misuse and metabolic wellness making people sober faster. 

For more information, visit www.QuantumBioPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM 

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• SPARC AI’s establishment of a wholly owned Ukrainian subsidiary marks a shift from distributor-led expansion to direct execution in one of the most operationally demanding drone warfare environments in the world.
• Ukraine’s battlefield conditions, including persistent GPS jamming and rapid drone deployment cycles, create a real-world proving ground few defense technology companies can replicate.
• With manufacturer partnerships, operator relationships, and a permanent in-country team, SPARC AI is building both distribution infrastructure and field validation simultaneously.

Modern warfare is increasingly being shaped by software rather than hardware alone. As Ukraine’s drone campaign expands deeper into Russian territory and the Pentagon evaluates Ukrainian combat drones and electronic warfare systems for potential procurement, defense priorities are shifting toward technologies that can preserve navigation, targeting, and operational continuity when conventional systems fail. In contested environments, GPS denial is no longer a theoretical problem. It is an active battlefield constraint.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is positioning itself around that exact challenge. Early in May, the company announced plans to establish a permanent operational presence in Ukraine through a wholly owned subsidiary intended to accelerate adoption of its Overwatch software platform across the country’s defense drone ecosystem. The move includes hiring a local country manager, business development personnel, and engineering support to facilitate software deployment, customer integration, and field operations.

For a company commercializing GPS-denied navigation software, Ukraine is not simply another market opportunity. It is arguably the most relevant operating environment available.

Why Ukraine Matters

Ukraine has become one of the most technologically demanding combat environments for autonomous systems anywhere in the world. Russian electronic warfare capabilities routinely disrupt GPS signals, forcing Ukrainian operators to adapt rapidly in real time. Drone warfare has evolved from tactical reconnaissance into a core element of battlefield strategy, with Ukrainian forces increasingly using low-cost FPV drones to disrupt logistics, target command infrastructure, and strike deeper into contested territory. A recent overnight strike on the heavily defended Moscow Oil Refinery, which was reportedly forced to temporarily halt operations, illustrated how far that reach has extended.

President Volodymyr Zelenskyy recently indicated that Ukraine had expanded its mid-range strike contracting at five times the pace of the prior year, underscoring how quickly drone-dependent operations are scaling.

This environment directly aligns with SPARC AI’s thesis. Overwatch is designed to enhance positioning accuracy by leveraging sensors already embedded within drone platforms, rather than requiring additional hardware modifications. That software-based model has potential commercial advantages, particularly in defense environments where deployment speed, cost efficiency, and scalability matter.

Just as importantly, each field deployment creates operational feedback that can improve the system’s machine learning performance over time.

Building Distribution from Both Directions

The Ukrainian subsidiary is not an isolated development. It represents the next stage of a broader commercialization strategy that has been taking shape over recent months.

In April, SPARC AI announced its second Ukrainian drone manufacturer partnership, adding to an earlier agreement in the region. The company also entered an arrangement with a member of the Ukrainian National Guard involved in drone pilot training, creating another channel into active operator networks.

Outside Ukraine, SPARC AI has also announced a U.S.-based partnership with Rate Manufacturing to integrate Overwatch into its Model-F multi-mission drone systems. The company has also established a distribution relationship with Precision Technic Defense Group covering European markets, an Indian drone manufacturer partnership, and an arrangement with a group working closely with the United Arab Emirates Ministry of Defense.

The strategy appears deliberate.

By embedding Overwatch directly into manufacturer platforms while also building relationships with operators using those systems in the field, SPARC AI is pursuing both supply-side integration and real-world validation at the same time. Manufacturers create deployment scale. Operators generate performance data and practical credibility.

That combination could prove important if the company seeks broader defense adoption.

The Broader Defense Shift

The Pentagon’s growing interest in Ukrainian battlefield technologies suggests that software-defined defense systems are becoming a strategic priority.

According to recent reporting, the U.S. Department of Defense is seeking to evaluate Ukrainian drones and electronic warfare systems domestically, with particular interest in combat-tested technologies that solve modern battlefield problems. Secretary of the Army Dan Driscoll recently described Ukraine’s integrated drone operating network as a capability the U.S. military currently lacks. On May 12, 2026, the State Department and Ukrainian Ambassador Olha Stefanishyna negotiated a draft memorandum outlining a defense agreement that would allow Kyiv to export its combat-tested military technology to American manufacturers, a first step toward establishing joint drone manufacturing ventures.

That backdrop matters.

As electronic warfare threats expand and GPS spoofing becomes more common, the demand for alternative navigation and targeting solutions may extend beyond active conflict zones into broader military and commercial autonomy markets.

SPARC AI’s software-centric approach could fit that trend, particularly if Overwatch demonstrates repeatable performance across larger deployments.

Execution Still Matters

The commercial case remains early stage.

Defense technology companies often face long procurement cycles, pilot programs that never convert, and ongoing validation requirements across multiple operating environments. SPARC AI is no exception.

The company still needs to demonstrate that Overwatch can perform consistently at scale and that its growing network of partnerships can translate into recurring commercial contracts.

Still, the company’s recent actions suggest a transition from concept to execution.

Rather than discussing theoretical market opportunities, SPARC AI is placing personnel inside the environment most likely to stress-test its technology.

In a defense market increasingly shaped by software resilience rather than hardware alone, that may prove to be the more important signal.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• Private investment in the space sector reached record levels in 2025, with momentum expected to continue as defense spending, sovereign satellite investment, and launch infrastructure demand accelerate.
• Planet Ventures is pursuing a public-market investment model designed to give shareholders access to private aerospace and space technology companies that have historically been the domain of venture and institutional capital.
• The company’s growing portfolio spans launch systems, orbital infrastructure, satellite-adjacent technologies, and aerospace innovation across multiple segments of the expanding space economy.

The global space economy is entering another expansion phase, but unlike earlier cycles driven primarily by speculative launch enthusiasm, the current wave is being shaped by infrastructure, defense priorities, and strategic capital deployment. According to Reuters, private investment in the sector climbed 48% in 2025 to a record $12.4 billion, with continued growth expected in 2026 as governments increase defense-linked spending and private investors expand exposure to launch capacity, satellite systems, and AI-integrated aerospace technologies.

That backdrop is reshaping how investors think about the sector. Direct access to private aerospace companies remains limited for most public market participants, particularly as many of the most closely watched opportunities remain venture-backed or institutionally financed. Planet Ventures (CSE: PXI) (OTC: PNXPF) has built its strategy around that structural gap.

A Public Vehicle Built Around Private Space Exposure

Planet Ventures is structured as an investment issuer focused specifically on identifying and investing in innovative companies operating across the space and aerospace sectors. Rather than functioning as a single-product aerospace operator, the company is pursuing a portfolio-based investment model intended to provide shareholders with indirect exposure to emerging private companies positioned across different layers of the space economy.

That distinction matters. The commercial space sector remains capital intensive, technologically complex, and often inaccessible to traditional retail investors. Many private aerospace companies raise capital through venture networks, strategic investors, or institutional channels long before broader public market participation becomes possible. Planet’s strategy is built around creating access through public ownership.

According to the company, its investment focus spans both upstream and downstream segments of the space economy, including launch infrastructure, spacecraft manufacturing, satellite communications, Earth observation, navigation systems, and adjacent aerospace technologies.

Building Exposure Across Multiple Space Themes

The broader sector opportunity extends well beyond rockets. As commercial activity expands, the addressable opportunity increasingly includes the infrastructure required to support persistent space operations, including manufacturing, orbital logistics, communications systems, and mission-enabling technologies.

Planet Ventures’ portfolio reflects that broader view. The company’s website identifies investments that include exposure to Antaris Inc., Mantis Space, Galactic Resource Utilization Space Inc., General Astronautics, and Lux Aeterna. This diversified structure gives the company exposure across multiple emerging themes rather than concentrating risk in a single operating asset.

That portfolio-style approach aligns more closely with venture investing than traditional single-company public equity exposure. For investors seeking participation in the commercial space buildout, diversification may matter given the long timelines, technical hurdles, and capital requirements that often define aerospace development.

The Macro Environment Has Shifted

Space investment is no longer being framed purely as a speculative frontier capital. Governments increasingly view orbital infrastructure, satellite capability, and aerospace manufacturing as strategic assets tied to national security and economic competitiveness, and that shift has accelerated capital flows into the sector.

Reuters recently reported that U.S. investment accounted for approximately 60% of global private space funding in 2025, driven heavily by launch services and defense-related initiatives. Analysts expect further momentum from sovereign satellite investment, missile defense priorities, and broader commercialization of space-enabled infrastructure.

Private market participation has followed that trend. For companies like Planet Ventures, that creates an environment where access itself may become a differentiator. Rather than attempting to build operating infrastructure directly, the company is positioning around ownership exposure to businesses pursuing that work.

A Different Kind of Space Market Story

The company’s model offers a distinct public-market approach to a sector where access has historically been constrained. The commercial space economy is increasingly attracting serious capital, but much of the most compelling activity continues happening behind private financing rounds rather than on public exchanges. Planet Ventures is attempting to bridge that gap.

For investors who view the next phase of aerospace growth as being driven by infrastructure, strategic investment, and private innovation rather than short-term speculation, that model presents a differentiated way to think about exposure.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. 

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

• Lahontan has mobilized a second drill rig to Santa Fe following approval of its exploration Plan of Operations, opening access to more than 700 new drill locations across its Nevada land package. 
• Recent cyanide extractable analyses from the 2025 reverse-circulation program at West Santa Fe averaged 81% gold and 60% silver recoveries, supporting the project’s heap-leach processing thesis. 
• The Santa Fe Mine combines past production history, a defined NI 43-101 resource base, and a development pathway management has publicly outlined. 

Junior mining capital has narrowed considerably. Exploration stories that once attracted financing on geological thesis alone are now being asked to demonstrate something more tangible: permitting visibility, infrastructure context, metallurgical results, and a realistic pathway toward production. In that environment, companies attracting attention are increasingly those positioned closer to production rather than still defining a target. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) fits that profile more cleanly than many of its peers.

A Past Producer, not a Concept

The company’s flagship 28.3 km² Santa Fe Mine project sits in Nevada’s Walker Lane and is not a conceptual exploration target. The property previously produced 359,202 ounces of gold and 702,067 ounces of silver between 1988 and 1995 through open pit mining and heap-leach processing. That production history provides operational precedent, infrastructure context, and geological validation that purely greenfield programs cannot offer.

The current NI 43-101 compliant resource estimate includes an indicated resource of 1,539,000 gold-equivalent ounces and an inferred resource of 411,000 gold-equivalent ounces, giving the company a defined asset base to advance rather than build from scratch. Management has publicly framed 2027 as a target window for resumption of mining operations at Santa Fe, anchoring the development narrative to a stated timeline rather than open-ended exploration.

Permitting Progress Opens a Much Larger Footprint

One of the more meaningful recent catalysts arrived in March, when Lahontan mobilized a track-mounted reverse-circulation drill rig to Santa Fe following approval of its exploration Plan of Operations. The new rig augments a diamond rig already on site and provides access to more than 700 new permitted drill locations across the project.

This materially expands the project’s exploration flexibility. Most prior drilling had focused on resource definition and expansion tied to development planning. The added capacity now allows the company to test areas of the property that were under-explored or overlooked by previous operators, broadening the work program across what management describes as a district-scale land package.

For junior developers, this category of progress is often underappreciated. Capital-intensive projects routinely stall when regulatory pathways remain unclear and having that framework approved removes a layer of execution risk that many earlier-stage peers continue to carry.

Metallurgy Strengthens the Economic Narrative

Resource ounces alone do not establish a viable mine. Processing economics frequently determines whether ounces in the ground translate into recoverable, economic metal, making metallurgical performance a critical variable in any production case.

That context makes Lahontan’s April announcement particularly relevant. The company reported extractable cyanide recoveries averaging 81% for gold and 60% for silver from 158 pulp samples taken from its 2025 reverse-circulation drilling program at West Santa Fe. Cyanide extractable gold results ranged from 41% to greater than 100%, while silver results ranged from 19% to 91%.

The results compared favorably with historical recovery assumptions previously associated with the project and support continued metallurgical optimization work. For Nevada gold projects, heap-leach compatibility remains one of the more important inputs into capital intensity and operating costs. Santa Fe also carries historical heap-leach operating precedent, making the metallurgical case less theoretical than at an early-stage asset.

A Better Match for Today’s Capital Environment

The broader junior mining environment remains challenging. Exploration companies continue competing for capital in a market increasingly demanding clearer pathways to execution and visible near-term catalysts. Discovery stories still attract attention, but investor focus has shifted toward issuers that can demonstrate infrastructure, defined resources, permitting status, and operational de-risking working in combination.

Lahontan’s positioning reflects that shift. The combination of a past-producing asset, an updated resource estimate, expanded drilling capacity, validated metallurgy, and a stated production objective creates a profile that reads differently from peers still building the foundational geological case.

Execution risk has not been removed. Additional drilling, an updated Preliminary Economic Assessment, engineering work, and financing milestones will ultimately determine the pace at which Santa Fe advances.

What has changed is the composition of the story. In a sector where credibility is increasingly tied to what comes after exploration, Lahontan is presenting a development narrative that more closely aligns with what the market has shown a willingness to fund.

For more information, visit the company’s website at www.LahontanGoldCorp.com. 

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF